Tried and tested oxygen concentrators for use in low-resource settings.
Comprehensive lab testing of 11 models across 2023–2024.
Models tested11
Testing period2023–2024
PartnersECRI & LabTest Certification
Funded byFCDO
"The CoLab put out the Oxygen Concentrator Directory to bring transparency to the market.
We hope this catalyses efforts to improve access to medical oxygen in low-resource settings
through the manufacturing and purchasing of fit-for-purpose oxygen concentrators."
— Nick Moore, Oxygen CoLab Operations Lead
Use this resource to
Make informed purchasing decisions based on your facility's environment and conditions.
Advocate for the procurement of concentrators suited to your health system or facility.
Improve the longevity of concentrators in use through understanding their strengths and weaknesses.
Why we did this testing
Sharp inequities regarding medical oxygen access were highlighted during the COVID-19 pandemic, leading to increased
momentum from donors and global actors. Oxygen concentrators have a particularly important role in low-resource
settings — especially smaller and more remote health facilities — and in low- and middle-income countries (LMICs)
where access to large-scale oxygen sources is often unavailable or limited.
With many different makes and models available, a gap remained in evidence on performance, safety, usability,
repairability, electrical resilience and energy efficiency. The Oxygen CoLab, a
UK FCDO-funded
initiative, undertook comprehensive lab testing of 11 models. Working with
LabTest Certification and
ECRI,
testing replicates real-world performance scenarios in challenging environments: high heat and humidity,
electricity volatility, and heavy dust.
Who is this for?
Any stakeholder along the medical oxygen supply chain with an interest in the performance, quality, and safety of oxygen concentrators.